Affinia Therapeutics is a biotech company developing transformative gene therapies for cardiovascular and neurological diseases. We are backed by a strong syndicate of life science investors and have ambitious plans to have a dramatic impact on the lives of patients around the world. The pace of work is dynamic, fast and fun.